Noevir Holdings Co Ltd
TSE:4928
Noevir Holdings Co Ltd
Operating Income
Noevir Holdings Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Noevir Holdings Co Ltd
TSE:4928
|
Operating Income
¥11.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
|
Shiseido Co Ltd
TSE:4911
|
Operating Income
¥19.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-9%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Operating Income
¥40.6B
|
CAGR 3-Years
25%
|
CAGR 5-Years
14%
|
CAGR 10-Years
9%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Operating Income
¥16.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
0%
|
|
Kao Corp
TSE:4452
|
Operating Income
¥86.6B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-4%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Operating Income
¥25.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
See Also
What is Noevir Holdings Co Ltd's Operating Income?
Operating Income
11.2B
JPY
Based on the financial report for Dec 31, 2023, Noevir Holdings Co Ltd's Operating Income amounts to 11.2B JPY.
What is Noevir Holdings Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
4%
Over the last year, the Operating Income growth was -1%. The average annual Operating Income growth rates for Noevir Holdings Co Ltd have been 13% over the past three years , and 4% over the past ten years .